The Genetic Landscape of Hypoplastic Left Heart Syndrome

[1]  T. Karamlou,et al.  Evolution of care pathways for babies with hypoplastic left heart syndrome: integrating mechanistic and clinical process investigation, standardization, and collaborative study , 2020, Journal of thoracic disease.

[2]  F. Jamali,et al.  Single dose pharmacokinetics and bioavailability of glucosamine in the rat. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[3]  C. Lo,et al.  Genetics of Congenital Heart Disease , 2019, Biomolecules.

[4]  M. Friedberg,et al.  Cardiac regenerative capacity is age- and disease-dependent in childhood heart disease , 2018, PloS one.

[5]  Simon Watkins,et al.  The complex genetics of hypoplastic left heart syndrome , 2017, Nature Genetics.

[6]  L. Pile,et al.  The Transcriptional Corepressor SIN3 Directly Regulates Genes Involved in Methionine Catabolism and Affects Histone Methylation, Linking Epigenetics and Metabolism* , 2016, The Journal of Biological Chemistry.

[7]  Y. Liao,et al.  Genome-wide analysis of alternative splicing during human heart development , 2016, Scientific Reports.

[8]  H. Schulz,et al.  Transcriptional profiling of regenerating embryonic mouse hearts , 2016, Genomics data.

[9]  Gene W. Yeo,et al.  Rbfox2 function in RNA metabolism is impaired in hypoplastic left heart syndrome patient hearts , 2016, Scientific Reports.

[10]  Y. Pinto,et al.  RNA Splicing: Regulation and Dysregulation in the Heart. , 2016, Circulation research.

[11]  N. Silverman,et al.  Right Ventricular Systolic-to-Diastolic Time Index: Hypoplastic Left Heart Fetuses Differ Significantly from Normal Fetuses. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  Stephan J Sanders,et al.  De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies , 2015, Science.

[13]  S. Body,et al.  Embryonic Development of the Bicuspid Aortic Valve , 2015, Journal of cardiovascular development and disease.

[14]  Eric D Wieben,et al.  Recessive MYH6 Mutations in Hypoplastic Left Heart With Reduced Ejection Fraction , 2015, Circulation. Cardiovascular genetics.

[15]  M. de Andrade,et al.  Compound heterozygous NOTCH1 mutations underlie impaired cardiogenesis in a patient with hypoplastic left heart syndrome , 2015, Human Genetics.

[16]  R. Arnold,et al.  Hypoplastic Left Heart Syndrome – Unresolved Issues , 2014, Front. Pediatr..

[17]  M. Looso,et al.  RBM24 is a major regulator of muscle-specific alternative splicing. , 2014, Developmental cell.

[18]  Lisa J. Martin,et al.  Whole Exome Sequencing for Familial Bicuspid Aortic Valve Identifies Putative Variants , 2014, Circulation. Cardiovascular genetics.

[19]  J. Tapia,et al.  Single-Cell Identity Generated by Combinatorial Homophilic Interactions between α, β, and γ Protocadherins , 2014, Cell.

[20]  S. Emani,et al.  Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome: Postnatal Outcomes of the First 100 Patients , 2014, Circulation.

[21]  J. Rychik.  Hypoplastic left heart syndrome: can we change the rules of the game? , 2014, Circulation.

[22]  J. Rychik,et al.  Diagnosis and Treatment of Fetal Cardiac Disease: A Scientific Statement From the American Heart Association , 2014, Circulation.

[23]  A. Terzic,et al.  Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy. , 2014, Human molecular genetics.

[24]  G. Christofori,et al.  The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion , 2014, Oncogene.

[25]  L. Reinholdt,et al.  Interrogating Congenital Heart Defects With Noninvasive Fetal Echocardiography in a Mouse Forward Genetic Screen , 2014, Circulation. Cardiovascular imaging.

[26]  M. Brueckner,et al.  The Heterotaxy gene, GALNT11, glycosylates Notch to orchestrate cilia type and laterality , 2013, Nature.

[27]  L. Scorrano,et al.  Mitochondrial Fusion Directs Cardiomyocyte Differentiation via Calcineurin and Notch Signaling , 2013, Science.

[28]  A. Terzic,et al.  Natural Cardiogenesis-Based Template Predicts Cardiogenic Potential of Induced Pluripotent Stem Cell Lines , 2013, Circulation. Cardiovascular genetics.

[29]  P. Shannon,et al.  Fetal reprogramming and senescence in hypoplastic left heart syndrome and in human pluripotent stem cells during cardiac differentiation. , 2013, The American journal of pathology.

[30]  T. Maniatis,et al.  Clustered protocadherins , 2013, Development.

[31]  Fatih Kocabaş,et al.  Meis1 regulates postnatal cardiomyocyte cell cycle arrest , 2013, Nature.

[32]  J. Manikandan,et al.  Differential gene expression profiles during embryonic heart development in diabetic mice pregnancy. , 2013, Gene.

[33]  R. Schwartz,et al.  Hemogenic endocardium contributes to transient definitive hematopoiesis , 2013, Nature Communications.

[34]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[35]  V. Mor-Avi,et al.  Bicuspid aortic valve: inter-racial difference in frequency and aortic dimensions. , 2012, JACC. Cardiovascular imaging.

[36]  M. Bronner,et al.  A PHD12–Snail2 repressive complex epigenetically mediates neural crest epithelial-to-mesenchymal transition , 2012, The Journal of cell biology.

[37]  M. Capecchi,et al.  Protocadherin clusters and cell adhesion kinase regulate dendrite complexity through Rho GTPase. , 2012, Journal of molecular cell biology.

[38]  L. Galletti,et al.  Identification of de novo mutations and rare variants in hypoplastic left heart syndrome , 2012, Clinical genetics.

[39]  S. Lipshultz,et al.  Myocardial Alternative RNA Splicing and Gene Expression Profiling in Early Stage Hypoplastic Left Heart Syndrome , 2012, PloS one.

[40]  Gerard R Martin,et al.  Hypoplastic left heart syndrome: current considerations and expectations. , 2012, Journal of the American College of Cardiology.

[41]  K. Yutzey,et al.  Twist1 Directly Regulates Genes That Promote Cell Proliferation and Migration in Developing Heart Valves , 2011, PloS one.

[42]  H. Marr,et al.  Rbfox-regulated alternative splicing is critical for zebrafish cardiac and skeletal muscle functions. , 2011, Developmental biology.

[43]  Y. Tomita,et al.  Role of Meis1 in mitochondrial gene transcription of pancreatic cancer cells. , 2011, Biochemical and biophysical research communications.

[44]  D. Moodie.  Adult congenital heart disease: past, present, and future. , 2011, Texas Heart Institute journal.

[45]  Y. Kluger,et al.  The Mammalian Sin3 Proteins Are Required for Muscle Development and Sarcomere Specification , 2010, Molecular and Cellular Biology.

[46]  B. Zhou,et al.  The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1 , 2010, The EMBO journal.

[47]  Allan Kuchinsky,et al.  Alternative Splicing in the Differentiation of Human Embryonic Stem Cells into Cardiac Precursors , 2009, PLoS Comput. Biol..

[48]  P. Pellikka,et al.  Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[49]  S. Tevosian,et al.  Cardiac Expression of Tnnt1 Requires the GATA4-FOG2 Transcription Complex , 2009, TheScientificWorldJournal.

[50]  R. Hetzer,et al.  Staged Surgical Palliation in Hypoplastic Left Heart Syndrome and Its Variants , 2009, Journal of cardiac surgery.

[51]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[52]  R. Bronson,et al.  SRp38 regulates alternative splicing and is required for Ca(2+) handling in the embryonic heart. , 2009, Developmental cell.

[53]  Lisa J. Martin,et al.  Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. , 2009, Journal of the American College of Cardiology.

[54]  R. Chang,et al.  Decreasing number of deaths of infants with hypoplastic left heart syndrome. , 2008, The Journal of pediatrics.

[55]  K. Helin,et al.  Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor , 2008, Molecular and Cellular Biology.

[56]  J. Borlak,et al.  A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. , 2008, Human molecular genetics.

[57]  Shigeyuki Esumi,et al.  The protocadherin-α family is involved in axonal coalescence of olfactory sensory neurons into glomeruli of the olfactory bulb in mouse , 2008, Molecular and Cellular Neuroscience.

[58]  John K. Triedman,et al.  Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery , 2008, Circulation.

[59]  Lisa J. Martin,et al.  Hypoplastic left heart syndrome is heritable. , 2007, Journal of the American College of Cardiology.

[60]  F. Grosveld,et al.  Transcription Factor Sp3 Knockout Mice Display Serious Cardiac Malformations , 2007, Molecular and Cellular Biology.

[61]  J. Rossant,et al.  Baf60c is a nuclear Notch signaling component required for the establishment of left–right asymmetry , 2007, Proceedings of the National Academy of Sciences.

[62]  R. Hinton,et al.  Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations , 2007, Human Genetics.

[63]  C. Tabin,et al.  Development of heart valves requires Gata4 expression in endothelial-derived cells , 2006, Development.

[64]  J. Belmont,et al.  Epidemiology of noncomplex left ventricular outflow tract obstruction malformations (aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome) in Texas, 1999-2001. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[65]  S. Leal,et al.  Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: Segregation, multiplex relative risk, and heritability , 2005, American journal of medical genetics. Part A.

[66]  Shigeyuki Esumi,et al.  Monoallelic yet combinatorial expression of variable exons of the protocadherin-α gene cluster in single neurons , 2005, Nature Genetics.

[67]  J. Belmont,et al.  Echocardiographic Evaluation of Asymptomatic Parental and Sibling Cardiovascular Anomalies Associated With Congenital Left Ventricular Outflow Tract Lesions , 2004, Pediatrics.

[68]  F. Portillo,et al.  Transcriptional regulation of cadherins during development and carcinogenesis. , 2004, The International journal of developmental biology.

[69]  K. Jones,et al.  The 11q terminal deletion disorder: A prospective study of 110 cases , 2004, American journal of medical genetics. Part A.

[70]  J. Smallhorn,et al.  Intrauterine pulmonary venous flow and restrictive foramen ovale in fetal hypoplastic left heart syndrome. , 2004, Journal of the American College of Cardiology.

[71]  A. Chokkalingam,et al.  Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d‐transposition of the great arteries , 2004, American journal of medical genetics. Part A.

[72]  D. Elliott,et al.  Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. , 2003, Journal of the American College of Cardiology.

[73]  P. Stoutenbeek,et al.  Prenatal Diagnosis of the Fetus with Hypoplastic Left Heart Syndrome , 2003, Herz.

[74]  M. Feldman,et al.  Extensive linkage disequilibrium, a common 16.7-kilobase deletion, and evidence of balancing selection in the human protocadherin alpha cluster. , 2003, American journal of human genetics.

[75]  L. Bailey,et al.  Identification of connexin43 (alpha1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE). , 2001, Mutation research.

[76]  S. Siu,et al.  Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.

[77]  W. Gersony,et al.  Survival and risk factor analysis for the Norwood procedure for hypoplastic left heart syndrome. , 1997, The American journal of cardiology.

[78]  T. Beaty,et al.  Assessing familial aggregation of congenital cardiovascular malformations in case‐control studies , 1988, Genetic epidemiology.

[79]  J. M. Optiz,et al.  Update on counseling the family with a first-degree relative with a congenital heart defect. , 1988, American journal of medical genetics.

[80]  R. Kelley,et al.  Association of Turner syndrome with hypoplastic left-heart syndrome. , 1987, American journal of diseases of children.

[81]  J. Frézal,et al.  [Epidemiological and genetic study of 3 congenital cardiopathies with neonatal disclosure]. , 1984, Archives francaises de pediatrie.

[82]  J. Warren,et al.  Risks to the offspring of patients with some common congenital heart defects. , 1981, Journal of medical genetics.

[83]  H. Laursen.  SOME EPIDEMIOLOGICAL ASPECTS OF CONGENITAL HEART DISEASE IN DENMARK , 1980, Acta paediatrica Scandinavica.